GCL
ENTL

Glazer Capital LLC’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Glazer Capital LLC’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-99,000
Closed -$2.42M – 132
2017
Q4 		$2.42M Buy
+99,000
New +$1.9M 0.39% 46

Glazer Capital LLC's ENTL Position: Q1 2018 in Review

Glazer Capital LLC sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 99,000 shares — an estimated $2.42M sold.

Glazer Capital LLC first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $2.42M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Glazer Capital LLC reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Glazer Capital LLC sold 99,000 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $2.42M.
  • Glazer Capital LLC first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Glazer Capital LLC's Entellus Medical, Inc. Common Stock position peaked at $2.42M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Glazer Capital LLC's 13F filing for Q1 2018, filed 11 May 2018.